# Current Clinical Status Assessment

**Patient**: Dylan Antonio Martinez Labastida  
**Medical Record**: 345370  
**Date of Assessment**: 14-07-2025  
**Age**: 8 years, 8 months  
**Service**: Pediatric ICU (U.C.I.)  

## Current Vital Signs
- **Temperature**: 37.0¬∞C (Normothermic)
- **Heart Rate**: 105 bpm
- **Respiratory Rate**: 24 breaths/min
- **Blood Pressure**: 112/68 mmHg
- **Weight**: 37.7 kg (baseline), currently managing fluid balance
- **Height**: 130 cm

## Current Active Diagnoses

### Primary Diagnoses
1. **Resolved Open Abdomen Status** ‚úÖ
2. **Abdominal Sepsis Under Treatment** üîÑ
3. **Post-operative LAPE + Sigmoid Lesion Closure + Ileostomy** (08.07.25) ‚úÖ
4. **Post-operative LAPE Secondary to Intestinal Perforation and Multiple Abdominal Abscesses** (06.07.25) ‚úÖ
5. **Post-operative Appendectomy** (Complicated Acute Appendicitis Phase IV - 26.06.25) ‚úÖ
6. **School Child with Obesity** üîÑ

### Resolved Conditions
- Hemodynamic instability (no longer requiring vasopressors)
- Respiratory failure (successfully extubated)
- Open abdomen (successfully closed)

## System-by-System Current Status

### üß† Neurological System
**Status**: **STABLE - SIGNIFICANT IMPROVEMENT**
- **Consciousness Level**: Alert and cooperative
- **Pain Management**: Buprenorfina 0.3 mcg/kg/h (reduced dose)
- **RASS Score**: Not sedated (previously -4 to -5)
- **FLACC Pain Score**: Previously 1 point
- **Cognitive Function**: Interacts appropriately, follows instructions
- **Neurological Examination**:
  - Pupils: Isometric and reactive to light (previously miotic)
  - No abnormal postures or movements
  - Normocephalic
- **Sedation Status**: Discontinued ‚úÖ
- **Pain Control**: NSAID doses adjusted for optimal control

### üíì Cardiovascular System
**Status**: **STABLE - EXCELLENT IMPROVEMENT**
- **Hemodynamic Support**: **None required** ‚úÖ (previously Adrenaline 0.03 mcg/kg/min)
- **Heart Rate**: 105 bpm (within normal range)
- **Blood Pressure**: 112/68 mmHg (within percentiles)
- **Cardiac Examination**:
  - Precordium: Normodinamic, normophonetic
  - Heart Sounds: Rhythmic, no murmurs
  - Pulses: Central and peripheral present, symmetric
  - Capillary Refill: 2 seconds (normal)
- **Fluid Balance**: Negative balance maintained
- **Edema Status**: Localized to hands only

### ü´Å Respiratory System
**Status**: **STABLE - MAJOR IMPROVEMENT**
- **Ventilation Support**: **None - Successfully extubated** ‚úÖ
- **Oxygen Support**: Puritan system (room air supplementation)
- **Respiratory Mechanics**: Symmetric, adequate
- **Chest Examination**:
  - Air Entry: Good bilateral
  - Breath Sounds: Vesicular, diminished at bases
  - Added Sounds: None
- **Complications**: 
  - Bilateral pleural effusion (managed with diuretics)
  - Post-extubation stridor resolved with therapy
- **Chest X-ray**: Bilateral pleural effusion, otherwise stable

### üçΩÔ∏è Gastrointestinal System
**Status**: **IMPROVING - FUNCTIONAL RECOVERY**
- **Nutritional Status**: **Transitioning to enteral feeding** üîÑ
- **Current Feeding**: 
  - NPO (Nothing by mouth) with solution scheme
  - Basal parenteral nutrition (NPT)
  - **NEW**: Enteral stimulation with liquid diet initiated ‚úÖ
- **Abdominal Examination**:
  - Appearance: Globose due to adipose tissue
  - Palpation: Soft, depressible, no masses
  - Peristalsis: Diminished but present
  - No peritoneal irritation signs
- **Ileostomy Status**: 
  - Pink borders, good vascularization
  - No compromise signs
  - Functioning appropriately
- **Surgical Wound**: 
  - Some erythema at borders
  - Abundant secretion (seroma characteristics)
  - Managed with regular curations by surgery team
  - No dehiscence

### ü©∏ Hematological/Infectious Disease System
**Status**: **CONTROLLED - ONGOING TREATMENT**
- **Temperature**: 37.0¬∞C (low-grade fever)
- **Infection Management**:
  - **Antibiotic**: Meropenem 120 mg/kg/day (monotherapy)
  - **Duration**: Day 7+ of current regimen
  - **Response**: No systemic inflammatory response signs
- **Inflammatory Markers**: Under surveillance
- **Fever Pattern**: Intermittent, managed without scheduled antipyretics
- **Thermal Curve**: Under active monitoring

### ü´ò Renal System
**Status**: **STABLE - GOOD FUNCTION**
- **Urine Output**: 1.2 ml/kg/hr (adequate)
- **Fluid Balance**: Negative balance maintained (-118 on day 7)
- **Diuretic Use**: Furosemide 10mg PRN q8h (for pleural effusion management)
- **Renal Function**: No acute kidney injury signs
- **Urinary Catheter**: Planned for removal
- **Electrolyte Status**: Under monitoring for imbalances

### üíä Current Medications
- **Analgesics**: 
  - Buprenorfina 0.3 mcg/kg/h (opioid, reduced dose)
  - NSAIDs (adjusted doses for pain control)
- **Antibiotics**: 
  - Meropenem 120 mg/kg/day
- **Diuretics**: 
  - Furosemide 10mg PRN q8h
- **Nutritional Support**: 
  - Basal parenteral nutrition (NPT)
  - Enteral liquid diet (newly initiated)

## Clinical Trajectory Assessment

### ‚úÖ Major Achievements
1. **Successful extubation** (Day 7) - No longer requires mechanical ventilation
2. **Hemodynamic stability** - No vasopressor requirement
3. **Abdominal wall closure** achieved (Day 6)
4. **Neurological recovery** - Alert, cooperative, pain-controlled
5. **Infection control** - Stable on monotherapy
6. **Enteral feeding initiation** - GI tract functional recovery

### üîÑ Ongoing Challenges
1. **Bilateral pleural effusion** - Requiring diuretic management
2. **Surgical wound secretion** (seroma) - Regular curations needed
3. **Abdominal sepsis** - Still under active treatment
4. **Nutritional rehabilitation** - Transitioning feeding methods

### ‚ö†Ô∏è Areas Requiring Monitoring
1. **Respiratory status** - Risk of re-intubation if complications arise
2. **Wound healing** - Seroma management and infection prevention
3. **Nutritional tolerance** - Enteral feeding advancement
4. **Infection markers** - Antibiotic response assessment
5. **Fluid balance** - Pleural effusion management

## Functional Status
- **Mobility**: Limited to bed rest (ICU setting)
- **Communication**: Appropriate for age, follows instructions
- **Pain Level**: Well-controlled with current regimen
- **Sleep Pattern**: Not sedated, natural sleep cycles
- **Family Interaction**: Able to interact with family members

## Prognosis Assessment
- **Short-term**: **Cautiously optimistic** - Significant improvements achieved
- **Medium-term**: **Reserved** - Still in critical care, complications possible
- **Long-term**: **To be determined** - Dependent on infection resolution and surgical healing

## Risk Stratification
- **Current Risk Level**: **Moderate** (improved from high)
- **Risk Factors**: 
  - Ongoing infection
  - Surgical complications
  - Potential re-intubation need
  - Nutritional challenges
- **Protective Factors**:
  - Hemodynamic stability
  - Neurological recovery
  - Successful extubation
  - Adequate pain control

## Care Priorities
1. **Infection resolution** - Complete antibiotic course
2. **Respiratory monitoring** - Prevent complications
3. **Nutritional advancement** - Progress enteral feeding
4. **Wound management** - Optimize healing
5. **Family support** - Continued communication and updates

**Assessment Date**: 14-07-2025  
**Next Assessment Due**: Daily evaluations in ICU setting  
**Clinical Status**: **Improving but delicate, not exempt from complications**